##plugins.themes.bootstrap3.article.main##

Objective: To determine the poor prognostic factors of chronic subdural hematomas in the Neurosurgery Departments of the existing University Hospitals in Antananarivo, Madagascar.

Methods: This was a multicenter, retrospective, cross-sectional, descriptive and analytical study of 125 cases of chronic subdural hematoma.

Results: Poor prognostic factors for chronic subdural hematoma were age (OR: 4.4100; p = 0.005), male gender (OR: 4.354; p = 0.008), head injury (OR: 5.2250; p = 0.001), arterial hypertension (OR: 3.773; p = 0.028), ethylism (OR: 5.9639; p = 0.035), anticoagulant use (OR: 5.785; p = 0.001), altered general condition (OR: 3.4000; p = 0.001) and low Glasgow (OR: 14.444; p = 0.001).

Conclusion: Identification of these mortality risk factors would be beneficial in improving and implementing appropriate management.

Introduction

Chronic subdural hematoma (CSDH) is a frequent pathology, particularly in elderly patients with risk factors such as anticoagulant use and chronic alcoholism. CSDH is often associated with minor head trauma, although non-traumatic mechanisms may also be involved. While surgical management, particularly drainage, generally offers good results, complications and significant mortality are still observed in some cases [1].

Mortality associated with CSDH results from a number of factors, including underlying comorbidities, postoperative complications, as well as patient-related factors such as advanced age. A better understanding of these factors is essential to identify high-risk patients, optimize therapeutic management and reduce adverse outcomes [2].

In this article, we propose to study the risk factors associated with mortality in patients with HSDC in the Neurosurgery departments of Antananarivo Madagascar. By combining an analysis of clinical, radiological and biological data, our aim is to provide an overview of the elements predictive of mortality and to propose recommendations for improving clinical practice.

Materials and Methods

This is a retrospective, multicenter, cross-sectional, descriptive and analytical study over a 48-month period, from January 2019 to December 2022. The study was carried out in the neurosurgery and intensive care units of three university hospitals in Antananarivo, Madagascar (CENHOSOA, CHU HJRA and CHU Anosiala). We included patients who were 18 years and older, admitted with chronic subdural hematoma with complete and actionable medical records.

Several sources of documents were used to carry out this study:

1) Inpatient register listing all patients admitted to the department, their name, age, telephone number, medical file number, reason for admission and discharge diagnosis.

2) Patient medical records, which include personal information on each patient, detailed medical observations, treatment and monitoring records, and the results of any additional examinations carried out.

3) A surgical report book containing the patient’s name and age, the surgeon’s name, the type of operation, the progress of the procedure and a clinical summary.

The parameters studied are as follows:

1) Age and death,

2) Gender and death,

3) Antecedents: head trauma, chronic alcoholism, anticoagulant use, high blood pressure, diabetes, previous surgery and death,

4) Clinical factors: general condition the patient’s general condition on admission assessed by the WHO performance status index (Good general condition: 0, Fair general condition:1–2, Impaired general condition:3–4), state of consciousness and death,

5) Paraclinical factors: mass effect, laterality and death,

6) Surgical management: type of surgery, delays in management and death, occurrence of recurrence in relation to type of surgery.

The obtained data was analyzed using WHO Epi-info version 3.5.4 and Excel 2016. To measure the relationship between two variables, we used the Chi-square statistical test with Odds ratio and 95% confidence interval. The threshold value of p < 0.05 was considered significant.

Prior to data collection, authorization was obtained from hospital directors and heads of the departments concerned. Respect for anonymity, confidentiality, personal and professional secrecy. The forms containing the information collected are kept in a safe place.

The current study has some limitations as well. First, this is a retrospective study, and therefore subject to the effects of confounding factors. Second, the sample size is small.

Results

The number of patients selected was 125: 28 patients in surgical intensive care units (35%) and 97 patients in neurosurgical units (65%). The majority of patients underwent surgery under general anaesthesia, i.e., 96% (120 patients). Age over 70 is a risk factor for mortality, and the higher the age, the greater the risk (OR = 4.4100; p = 0.005) (Table I).

Variables Deceased (n = 21) Live (n = 104) OR IC [95%] p-value
Age
 30–50 3 16 1
 50–70 6 56 3.7116 [1.2082–10.4322] 0.001
 >70 12 32 4.4100 [1.3872–12.9210] 0.005
Gender
 Female 9 14 1
 Male 12 90 4.3542 [1.4320–13.3226] 0.008
Head trauma
 No 2 20 1
 Yes 19 84 5.2250 [1.6601–16.4456] 0.001
Ethyl
 No 4 45 1
 Yes 17 59 5.9639 [1.5298–6.2856] 0.003
Previous surgery
 No 15 88 1
 Yes 6 16 1.250 [0.3731–4.1881] 0.717
Diabetes
 No 18 92 1
 Yes 5 12 1.5120 [0.5155–4.4346] 0.41
Table I. Predictive Factors of Mortality According to Socio-demographic Parameters

As demonstrated by the data in Table II, male gender is a risk factor for mortality in patients with HSDC, with an OR of 4.3542 [1.4320–13.3226] and a p of 0.008. Head trauma is significantly associated with mortality in patients with chronic subdural hematoma OR: 5.2250 [1.6601–16.4456]; p = 0.001. There was a significant association between chronic alcohol intake and death from chronic subdural hematoma OR: 5.9639 [1.5298–6.2856]; p = 0.035. Anticoagulant use is a risk factor for OR mortality: 5.7857 [1.6128–16.0207]; p = 0.001. Hypertension is significantly associated with mortality in chronic subdural hematoma OR: 3.7733 [1.5939–9.2952]; p = 0.028. There was no association between previous surgery and poor prognosis of chronic subdural hematoma OR: 1.250 [0.3731–4.1881] p = 0.717. There was no association between patient diabetes and mortality from chronic subdural hematoma OR: 1.5120 [0.5155–4.4346]; p = 0.41.

Variables Deceased (n = 21) Live (n = 104) OR IC [95%] p-value
General condition
 Good 3 26 1
 Fairly good condition 7 69 0.6759 [0.1818–2.512] Not significant
 Impaired general 11 9 3.4000 [1.0872–11.9210] 0.001
Glasgow
 15/15 3 69 1
 Between 8 and 13 8 32 6.3333 [1.4334–13.1003] 0.001
 Less than 8 10 3 14.444 [3.969–52.6360] 0.001
Mass effect
 No 4 13 1
 Yes 17 91 1.3478 [0.7901–6.9770] 0.118
Laterality
 Unilateral 11 77 0.6867 [0.2967–1.6213] 0.395
 Bilateral 10 27 1.3478 [0.9901–5.9770] 0.058
Table II. Predictors of Mortality based on Clinical and Paraclinical Parameters

Impaired general condition on admission is a risk factor for mortality in patients with chronic subdural hematoma OR: 3.4000 [1.0872–11.9210]; p = 0.001. Glasgow scores below 8 and between 13 and 8 are risk factors for mortality from chronic subdural hematoma. The lower the score, the higher the risk of mortality OR: 14.444 (3.969–52.6360]; p = 0.001. There was no association between the occurrence of mortality and the existence of the mass effect OR: 1.3478 [0.7901–6.9770]; p = 0.118. There was no significant association between mortality and bilateral hematoma OR: 1.3478 [0.9901–5.9770]; p = 0.058.

As demonstrated by the data in Table III, a delay in management of more than 5 days is a risk factor for mortality in DCSH, with a 95% OR CI of 4.7230 [1.6242–13.7188] and a p-value of 0.002. Of the 120 patients who underwent surgery, the enlarged trepan hole technique was used in 65% (78 patients), and the mini-flap technique with trephine was used in 35% (42 patients). There was no association between the occurrence of mortality and surgical technique, with an OR: 0.5264 [0.1828–1.5543], p = 0.237 for the enlarged trepan hole and an OR: 1.9172 [0.6568–5.6437], p = 0.237 for the mini-flap with trephine. There was no association between the occurrence of recurrence and the enlarged trephine hole surgical technique OR: 0.5276 [0.1034–2.7010], p = 0.429 nor with the mini-flap technique with trephine 1.9243 [0.3763–4.9876], p = 0.429.

Variables Deceased (n = 21) Live (n = 104) OR IC [95%] P
Time from diagnosis to surgery
 <=5 days 13 92 1
 >5 days 8 12 4.7230 [1.6242–13.7188] 0.002
Type of surgery
 Mini shutter with trephine 5 37 1.9172 [0.6568–5.6437] 0.237
 Enlarged drill hole 16 62 0.5264 [0.1828–1.5543] 0.237
Table III. Predictive Factors of Mortality according to Therapeutic Parameters

Discussion

According to the results of this study, there is a significant association between age over 70 and the occurrence of death from chronic subdural hematoma.

The higher the age, the greater the risk, with an OR CI of 4.4100 [1.3872–12.9210] and a p of 0.005, with a mortality rate of 17%. This is in line with a study carried out by Martial [3] in Limoges, which showed that all patients who died were over 60, with a death rate of 15%. A study carried out in Spain by Delgado et al. [4] on the early prognosis of chronic subdural hematomas. Multivariate analysis of 137 cases showed that advanced age tended to increase the risk of mortality (OR: 1.104), but did not reach statistical significance (p = 0.0654). Miranda et al. [1] in their study in the USA, in a multivariate analysis of chronic subdural haematoma in the elderly showed that age was a predictor of death after hospital discharge (OR = 1.06, p = 0.02). In his study of chronic subdural haematomas as a cause of morbidity and mortality in India, Ramachandran and Hedge [2] noted a death rate of 6%, which was significantly associated with advanced age (p = 0.003). Mortality is linked to the frailty of the elderly, who are more exposed to complications.

The association between male gender and poor prognosis of chronic subdural hematoma was significant in this study, with an OR of 4.3554 [1.4320–13.3226] and a p of 0.008. In the literature, male gender is considered a factor in the occurrence of mortality from chronic subdural hematoma. Indeed, a study carried out in Korea by Sim et al. [5], showed that the male gender is more exposed to CSHD due to its natural behavior characterized by overwork, high-risk work but also brutality, recklessness and delinquency which are observed in almost all cases of trauma whether cranioencephalic or general.

For Sim et al. [5] in Korea, in a comparative study between two groups over time which showed a rate in the recent group 15.7% significantly higher than in the distant groups which is 8.2%. This may be due to the current widespread use of anticoagulants, which may have changed the incidence of CSHD anticoagulants, recently considerably developed for the prevention of cardiovascular events. The results of this study also found a significant association between the mortality factors.

In Spain, Villagrasa et al. [6], in a retrospective statistical study analyzing prognostic factors in adults with chronic subdural hematoma, found that anticoagulant use was an independent factor in poor prognosis (OR: 7.2; 95% CI 3.9 to 9.5; p = 0.01). Diamond et al. [7], in England, assumed from a series of 22 patients with anticoagulant-associated subdural hematoma that the clinical course in patients on anticoagulants was more rapid than in those not on anticoagulants. A history of anticoagulant use would increase the risk of death in subdural hematoma.

In France, Decaux et al. [8] showed a 50% association between chronic alcoholism and CSHD. In Korea, Sim et al. [5] found a history of alcoholism in 21% of patients who underwent surgery for CSDH. The results of this study also demonstrated that long-term alcohol consumption is a poor prognostic factor for CSHD OR: 5.9639 [1.5298–6.2856] p = 0.003. Diallo et al. [9] in a retrospective analytical study in Senegal concerning the fate of alcohol-associated chronic subdural hematoma, found 14.9% with a history of alcoholism. They also noted that alcoholism is most often a poor prognostic factor in the management of CSHD, with 50% (5 out of 11 patients) having neurological sequelae. However, no deaths were reported, which differs slightly from our results. This poor prognosis may be linked to the fragility of the vessels induced by long-term alcohol consumption, and increases the risk of acute recurrence of the haematoma [10].

The results of this study showed that comatose state had a significant relationship with the occurrence of mortality in HSDC, with an OR: 14.444 [3.969 52.6360] and p = 0.001. Miranda et al. [1] in the USA, in their 2012 study, showed that the only predictor of in-hospital death was neurological status on admission (OR: 2.1, p = 0.02); in India, Ramachandran and Hedge [2] also demonstrated that when the Glasgow score was below 8, the risk of death was 35%, and this result was statistically significant (p < 0.001). Kim et al. [11] in Korea, in a study concerning prognostic factors in patients with chronic subdural hematoma, described that a low Glasgow score is an indicator of strong negative prognostic outcomes in CSHD (p < 0.001). According to several studies, the Glasgow score is a factor determining prognosis: the lower it is, the higher the mortality [1]. Fragile terrain with altered consciousness may explain this mortality.

In the present study, there was a significant association between the occurrence of CSHD -related mortality and a delay in management of more than 5 days, with a [95%] OR CI of 4.7230 [1.6242–13.7188] and a p-value = 0.002. To reduce mortality, it is important to perform surgery as soon as possible. Surgery is the mainstay of treatment for CSHD, and consists of evacuation of the subdural hematic collection, followed by flushing to remove the anticoagulant and fibrinolytic contents. All of this helps to ensure cerebral decompression and a return to normal local hemostasis [11]. The procedure is generally performed under general anesthesia, depending on the patient’s clinical condition. All our patients had undergone surgery under general anaesthesia: 65% were operated on using an enlarged trepan hole (78 patients), and the mini- flap technique with trephine was used in 35% of cases (42 patients). Several studies have reported results in line with these findings, notably Olodo’s [12] study in Senegal, in which trepanation was virtually the most commonly used technique (96.15%), with only one patient requiring a flap. Dongmo et al. [13] in Cameroon noted almost the same proportions, with 77.5% trepanation and 22.5% cranial flap with trephine.

Depending on the surgical procedure, mortality is 20.5% for craniotomy and 1.6% for trepan hole [14]. In this series, there was no significant association between the occurrence of mortality and surgical technique, with an OR: 0.5264 [0.1828–1.5543], p = 0.237 for the enlarged trephine hole and an OR: 1.9172 [0.6568–5.6437], p = 0.237 for the mini-flap with trephine. In the USA, Miranda, et al. [1] noted that the type of intervention, whether or not surgery was performed, did not affect long-term or short-term mortality (OR: 0.24, p = 0.01).

Surgical technique has no influence on mortality, and each center has its own technique, according to its own practice. The results of this study also showed that there was no association between the occurrence of recurrence and the enlarged trephine surgical technique OR: 0.5276 [0.1034–2.7010], p = 0.429 nor with the mini-flap technique with trephine 1.9243 [0.3763–4.9876], p = 0.429. In contrast to the study carried out by Bencherif et al. [14] in Algeria, recurrence was mainly due to non-re-expansion of the brain, which in turn was related to the choice of surgical technique. They noted a recurrence rate of 11.62%, which is slightly higher than the result of that study.

Conclusion

It is important to identify these predictive factors of mortality, so as to improve and implement appropriate care. Elderly people and those around them should avoid situations and workplaces where there is a risk of trauma, respect traffic regulations to reduce the number of accidents on public roads, combat modifiable risk factors (chronic alcoholism, trauma, self- medication with antiplatelet agents, dehydration), guide elderly people in their movements to avoid falls, consult a doctor after a trauma, however minor.

References

  1. Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg. 2011;114:72–6.
     Google Scholar
  2. Ramachandran R, Hegde T. Chronic subdural hematomas—causes of morbidity and mortality. Surg Neurol. 2007;67:367–72.
     Google Scholar
  3. Martial P. Hematome sous dural chronique de l’adulte: Etude a propos de 140 cas . Unpublished doctoral dissertation, University of Limoges; 1991. https://cdn.unilim.fr/files/theses-exercice/M1991151.pdf.
     Google Scholar
  4. Delgado PD, Cogolludo FJ, Mateo O, Cancela P, García R, Carrillo R. Pronóstico precoz en los hematomas subdurales crónicos. Análisis multivariado de 137 casos [Early prognosis in chronic subdural hematomas. Multivariate analysis of 137 cases]. Rev Neurol. 2000;30:811–7.
     Google Scholar
  5. Sim YW, Min KS, Lee MS, Kim YG, Kim DH. Recent changes in risk factors of chronic subdural hematoma. J Korean Neurosurg Soc. 2012;52:234.
     Google Scholar
  6. Villagrasa J, Prat R, Díaz JF, Comuñas F. Análisis de los factores pronósticos en adultos con hematoma subdural crónico [Analysis of prognostic factors in adults with chronic subdural hematoma]. Neurologia. 1998;13:120–4.
     Google Scholar
  7. Diamond T, Gray WJ, Chee CP, Fannin TF. Subdural haematoma associated with long term oral anticoagulation. Br J Neurosurg. 1988;2:351–5.
     Google Scholar
  8. Decaux AO, Cador AB, Dufour BT, Jégo P, Cazalets AC, Laurat AE, et al. Traitement des hématomes sous-duraux chroniques. Rev Med Int. 2002;23:788–91.
     Google Scholar
  9. Diallo M, Tokpa A, Hamadassaliha A, Kourouma D, Diarra A, Sogoba Y, et al. Devenir de l’hématome sous-dural chronique associé à l’alcool: analyse rétrospective d’une série des cas. Service de neurochirurgie CHU Gabriel Touré de Bamako. Annales Africains de Médecine. 2021;15(1):4464–9.
     Google Scholar
  10. Masson E. Traitement des hématomes sous-duraux chroniques par les corticoïdes: à propos de deux observations [Treatment of chronic subdural hematomas with corticosteroids: about two cases]. La Revue de Médecine Interne 23(9):788–791.
     Google Scholar
  11. Kim TH, Park ES, Park JB, Kwon SC, Lyo I, Sim HB, et al. Outcome and prognostic factors in patients with chronic subdural hematoma classified according to the initial Glasgow Coma Scale score. Nerve. 2017;3:25–31.
     Google Scholar
  12. Olodo KPCG. Prise en charge des hématomes sous-duraux chroniques à l’unité de neurochirurgie du centre hospitalier régional de Ziguinchor. À propos de 34 cas [Management of chronic subdural hematomas at the neurosurgery unit of the regional hospital center of Ziguinchor: about 34 cases]. Doctoral Dissertation. Ziguinchor (SN): Université Assane Seck de Ziguinchor; 2022. Available from: https://rivieresdusud.uasz.sn/handle/123456789/1671.
     Google Scholar
  13. Dongmo L, Juimo AG, Eloundou NJ, Njamnshi AK, Avdeeva V, Tiyou C. Hématome sous-dural chronique au Cameroun [Chronic subdural hematoma in Cameroon]. Médecine d’Afrique Noire. 1999;46(3):158–60.
     Google Scholar
  14. Bencherif L, Boualag M, Guenene L, Abdennebi B. Prise en charge des hématomes sous-duraux chroniques cérébraux récidivants post traumatiques [Management of recurrent post traumatic chronic cerebral subdural hematomas]. Neurosurgery. 1990;26:771–3.
     Google Scholar


Most read articles by the same author(s)